Director of Biopharma Partnerships

October 19, 2024

Apply Now

Receive Emails with Similar Jobs

SAGA Diagnostics

WebsiteLinkedInAll Job Openings

SAGA Diagnostics is a pioneering company focused on revolutionizing the early detection of Molecular Residual Disease (MRD) to personalize cancer treatment. Their unique MRD testing platform, based on proprietary hybrid technologies utilizing next-generation sequencing (NGS) and digital PCR, enables highly sensitive and specific detection of residual cancer following treatment. By leveraging tumor-specific structural variants to create a unique genetic fingerprint for each patient's cancer, SAGA Diagnostics provides oncologists, researchers, and drug developers with precise tools to monitor treatment response and detect disease early. Their liquid biopsy test is designed to continuously monitor a patient's cancer through simple blood draws, offering clarity and confidence at all stages of treatment. This innovative approach is helping improve cancer therapy decision-making and is a valuable partner for biopharma in accelerating drug development and commercialization efforts.

Cancer companion diagnostics • Circulating tumor DNA analysis • Tissue analysis • Actionable mutations • Mutation screening

11 - 50 employees

🧬 Biotechnology

⚕️ Healthcare Insurance

💊 Pharmaceuticals

📋 Description

•SAGA Diagnostics is a personalized cancer diagnostics and disease monitoring company. •Seeking an experienced Director of Biopharma Partnerships to drive MRD platform uptake. •Pivotal in expanding partnerships and enhancing diagnostic services tailored to biopharma. •Collaborate with VP of Business Development and Partnerships. •Opportunity to help grow a rapidly scaling cancer genomics startup.

🎯 Requirements

•Bachelor’s degree in Life Sciences, Business Administration, or a related field; MBA or advanced degree preferred. •Minimum of 8-10 years of experience in business development within the biopharmaceutical or diagnostic industry, with a proven track record of successfully closing RUO through CDx deals. •Detailed knowledge of the minimal residual disease (MRD) diagnostics landscape and technologies, including emerging trends and innovations. •Strong understanding of the biopharma landscape, including drug development processes, regulatory environments, key players, and market dynamics. •Excellent communication, negotiation, and interpersonal skills, with the ability to influence stakeholders at all levels. •Strategic thinker with a results-oriented mindset and a passion for advancing healthcare through innovation. •Excellent English oral and written communication skills, including experience in developing and delivering presentations. •Extensive contracting and forecasting experience. •Knowledge of Product Development would be an advantage. •Strong troubleshooting and data interpretation skills. •Strong teamwork skills with a proven track record of working collaboratively to ensure the delivery of projects to meet challenging timelines. •Flexibility towards work assignments, new learning, and travel.

🏖️ Benefits

•The opportunity to develop cutting-edge automation solutions for genomic diagnostics. •Generous benefits package including medical, dental, vision, FSA, HRA, and paid parental leave. •Membership to SAGA’s Equity scheme.